Seattle, Sept. 08, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global e-prescribing market is estimated to be valued at US$ 1,655.06 million in 2022 and is expected to exhibit a CAGR of 18.5% during the forecast period (2022-2030).
Key Trends and Analysis of the Global E-Prescribing Market:
Increasing inorganic growth strategies such as acquisition by the market player is expected to drive the growth of global e-prescribing market over the forecast period. For instance, In April 2021, Cerner Corporation, Computers and information Technology Company, announced the acquisition of Kantar Health, a division of Kantar Group, a Life sciences company for US$ 375 million in cash, subject to adjustment. Kantar Health’s life sciences ability will be combined with Cerner’s collection of data (RWD) and technology and is expected to accelerate innovation in life sciences research and improve patient outcomes worldwide. This acquisition will help the company expand further in the pharmaceutical sector.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2636
Key Market Takeaways:
Among product type, the service segment is expected to generate significant revenue, owing to increasing launch of services platform. For instance, in December 2020 - WELL Health Technologies Corp, a healthcare company, announced it partnered with Canada Health Infoway, a healthcare company, to launch Infoway’s national e-prescribing service, PrescribeIT, with WELL’s OSCAR Pro Electronic Medical Records (EMR) software. Physicians and health care practitioners using OSCAR Pro will easily create, renew and cancel prescriptions electronically, while improving overall patient care through secure clinician messaging. WELL is offering an end-to-end solution from virtual and on-site patient consultation to electronic prescription, resulting in a better physician and patient experience. By partnering with PrescribeIT, health care practitioners, pharmacists and patients can ensures patient privacy and security of information.
North America is expected to hold the largest share in global e-prescribing market and is estimated to exhibit a CAGR of 18.5% during the forecast period (2022-2030), owing to increasing number of organic growth strategies such as acquisition by the market players is expected to boost the growth of global e-prescribing market over the forecast period. For instance, in December 2020, Cerner, Computers and information Technology Company, announced an agreement to acquire health division of Kantar, a life sciences company. With this acquisition, Cerner plans to acquire data to improve the safety, efficiency and efficacy of clinical research across life sciences, pharmaceuticals and health care. This acquisition will help Cerner’s Learning Health Network SM client consortium to more directly engage with life sciences for funded research studies.
Competitive Landscape:
Key players operating in the global e-prescribing market include, Allscripts Healthcare Solutions, Inc., Athenahealth, Inc., Change Healthcare Holdings, Inc., Cerner Corporation, Computer Programs and Systems Inc., DrFirst, Inc., eClinicalworks, Epic Systems Corporation, GE Healthcare, Henry Schein, Inc., Medical Information Technology, Inc., Practice Fusion, Inc., Quality Systems, Inc., RelayHealth Corporation, and Surescripts-RxHub, LLC.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2636
Market Segmentation:
- Global E-Prescribing Market, By Product Type:
- Software
- Services
- Global E-Prescribing Market, By Deployment:
- Web & Cloud-based
- On-premise
- Global E-Prescribing Market, By End User:
- Hospital
- Clinics
- Pharmacies
- Global E-Prescribing Market, By Region:
- North America
- By country
- US
- Canada
- By country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Country/Region
- South Africa
- Central Africa
- North Africa
- By Country/Region
- North America
Related Market Intelligence Reports:
Ureteral Stents Market, by Product Type (Double Pigtail Stents and Multiloop Stents), by Material Type (Metal Stents and Polymer Stents (Silicone Ureteral Stents, Hybrid Ureteral Stents, and Polyurethane Ureteral Stents)), by Application (Kidney Stones (Ureteroscopy, Lithotripsy, and Percutaneous Nephrolithotomy), Kidney Transplantation, Urinary Incontinence, Tumors, and Others), by End User (Hospitals, Gastrointestinal Surgery Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030
Inhalation Anesthetics Market, By Type (Desflurane, Sevoflurane, Isoflurane, and Other Types), By End-User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 – 2028
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
